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1. Introduction  
Osteoblasts, as well as osteocytes that are a terminally differentiated form of osteoblasts, are 
responsible for bone formation by producing bone matrix proteins, which subsequently 
induce tissue mineralization. Osteoblasts differentiate and mature from their progenitors in 
response to various regulatory factors including bone morphogenetic proteins (BMPs), 
Insulin-like growth factor 1 (IGF-1), fibroblast growth factor 2 (FGF-2), parathyroid hormone 
(PTH), tumor necrosis factor-α (TNF-α), Wnts, and extracellular matrix (ECM) signals. 
Matrix mineral deposition occurs at the terminal stage of osteoblast differentiation and is 
associated with maximal expression of osteocalcin (Ocn). 
Although several transcription factors, such as runt-related transcription factor 2 (Runx2), 
Osterix (Osx), and activating transcription factor (ATF) 4, have been demonstrated to be 
crucial to bone development, the molecular details of intracellular signals controlling stage-
specific osteoblast differentiation remain enigmatic. It is well recognized that the mitogen 
activated protein kinase (MAPK) superfamily, including p44/p42 extracellular signal-
regulated kinases (ERKs), p38 kinases, and p54/p46 c-Jun N-terminal kinases (JNKs), 
integrates signals from a diverse range of extracellular stimuli, and plays important roles in 
cellular functions such as proliferation, differentiation, and cell death in a variety of cell 
types. Despite intensive investigation, the physiological roles of MAPKs in osteogenic 
differentiation have not been clearly demonstrated. AMP-activated protein kinase (AMPK) 
is a serine-threonine kinase widely known as an essential regulator of energy homeostasis of 
cells. Interestingly, however, non-metabolic functions of AMPK, including its roles in cell 
differentiation have recently been demonstrated. Several recent studies including ours have 
indicated that the differentiation of osteoblasts is functionally associated with the AMPK 
activity.  
Being located in the skeletons, osteoblasts are constantly exposed to various forms of 
mechanical stresses. Many previous studies have indicated that mechanical stresses on 
osteoblasts affect their cell differentiation process, which may explain why moderate 
exercises contribute to healthy bone development. However, mechanical stresses often 
induce tissue inflammation in bones, especially when they are excessive. We and others 
have recently revealed that osteoblasts respond to mechanical stresses by expressing various 
inflammatory cytokines and chemokines, which is dependent on the activation of kinases, 
such as MAPKs.  
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In this chapter, I will first briefly review recent and basic knowledge about osteoblast 
functions. I will then try to review the contribution of various kinase signals, including 
MAPKs and AMPK, to the osteoblast differentiation process. Finally, I will review the 
known mechanisms of kinase activation by mechanical stresses in osteoblasts, as well as 
how the mechanical stress-activated kinases affect the physiological functions of osteoblasts, 
including cell proliferation, differentiation, survival and the expression of chemokines and 
cytokines. 
2. The basic picture of osteoblast functions  
In vertebrates, bone tissue constitutes the skeleton and provides mechanical support, 
motility, and protection of internal organs. Bone tissue also acts as a reservoir of biologically 
essential minerals including calcium, phosphate, and magnesium. Osteoblasts, as well as 
osteocytes are responsible for bone formation by producing bone matrix proteins, which 
subsequently induce tissue mineralization (Raisz and Kream 1983). Osteoblasts are derived 
from bone marrow mesenchymal stem cells (MSCs), and terminally differentiate into 
osteocytes in bone tissue. In contrast, osteoclasts, which are derived from bone marrow 
hematopoietic stem cells, are in charge of bone resorption. The growth and maintenance of 
bone mass are thus regulated by the coordinated actions of osteoblasts and osteoclasts. Bone 
remodelling is a dynamic and constant process even in adults, replacing approximately 15% 
of the trabecular and 3% of the cortical bones every year (Manolagas and Jilka 1995). 
Disturbance of this delicate balance in bone remodelling leads to various bone disorders. 
The most well-known is probably osteoporosis which affects over 200 million people world-
wide (Cooper, Campion, and Melton 1992) and is considered as a serious public health 
concern. Osteoporosis is caused by the relative increase of bone resorption resulting in 
decreased bone density and increased risk of fractures. In contrast, relative increase of bone 
formation causes disorders such as osteopetrosis and osteosclerosis. 
The coordinated balance of bone remodelling is established by multiple coupling 
mechanisms between osteoblasts and osteoclasts. The most noticeable mechanism is 
through RANK ligand (RANKL) expressed on the surface of osteoblasts. RANKL signals 
through RANK, a cell surface receptor expressed on osteoclasts (Yasuda et al. 1998; Lacey et 
al. 1998; Boyle, Simonet, and Lacey 2003). In a complex interplay with macrophage colony-
stimulating factor (M-CSF), which is also produced by osteoblasts, RANKL induces the 
maturation and activation of osteoclasts. Osteoblasts also secrete osteoprotegerin (Opg) that 
acts as an inhibitory decoy receptor for RANKL, and the expression ratio of RANKL to Opg 
by osteoblasts dictates osteoclastogenesis (Manolagas and Jilka 1995; Boyle, Simonet, and 
Lacey 2003). Thus osteoblasts are the central players of bone metabolism controlling both 
bone formation and resorption. 
2.1 Molecular mechanisms of osteoblast differentiation 
Osteoblasts are derived from MSCs, which have the potential to differentiate into myoblasts, 
fibroblasts, and chondrocytes, in addition to osteoblasts. Osteoblasts differentiate and 
mature from their progenitors in response to various regulatory factors including BMPs, 
Insulin-like growth factor 1 (IGF-1), fibroblast growth factor 2 (FGF-2), parathyroid hormone 
(PTH), tumor necrosis factor-α (TNF-α), Wnts, and ECM signals (Deng et al. 2008). 
Osteoblasts produce various bone matrix proteins during differentiation (Fig. 1). Matrix 
www.intechopen.com
 Roles of Kinases in Osteoblast Function 
 
315 
mineral deposition occurs at the terminal stage of osteoblast differentiation and is associated 
with maximal expression of Ocn (Hauschka et al. 1989).  
 
Fig. 1. Schematic presentation of osteoblast differentiation. Osteoblast differentiation is 
controlled by the expression of several transcription factors including Runx2, Osx, and 
ATF4. A series of proteins termed “osteogenic markers” contributing to bone matrix 
formation are produced during osteoblast differentiation in stage-specific manners. These 
proteins include ColI, Opn, and Ocn. 
Differentiation of MSCs into different lineages is governed by the expression of lineage-
specific transcription factors. Specifically, osteoblast differentiation is controlled by 
transcription factors including Runx2 and Osx. Gene deficiency of either Runx2 or Osx 
causes defective bone formation and lack of mature osteoblasts in mice, suggesting that both 
of these transcription factors are necessary for osteoblast differentiation in vivo (Ducy et al. 
1997; Komori et al. 1997; Nakashima et al. 2002). The Runx regulatory element is found in 
the gene promoter regions of major bone matrix proteins including collagen type I (ColI), 
osteopontin (Opn), bone sialoprotein (Bsp), and Ocn (Marie 2008), indicating that the 
expression of these proteins is directly regulated by Runx2. Furthermore, recent reports 
have indicated that Runx2 interacts with some other transcription factors, which either 
activates or repress the transcriptional activity of Runx2 (Karsenty 2008). Thus Runx2 
functions as a transducer through which various signals can modulate osteoblast 
differentiation. A typical example is Runx2-Smad interaction. Two Smad members, Smad1 
and Smad5 which are activated by BMPs, interact with Runx2 and enhance its 
osteoblastogenetic activity.  
The essential role of Osx, a zinc-finger protein with homology to the Sp1/Kruppel 
transcription factor family, in osteogenesis relies on its ability to regulate the expression of a 
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number of osteogenic markers such as Opn, Dickkoph-related protein 1 (Dkk1), and ColI. 
Furthermore, transcriptional regulators such as Nuclear factor of activated T-cells, cytoplasmic 
(NFATc) or Nucleolar protein 66 (NO66), a jumonji family histone demethylase, have been 
shown to interact with Osx and regulate its transcriptional responses (Koga et al. 2005; Sinha et 
al. 2010). Osx has been generally believed as a downstream transcription factor of Runx2, as 
Osx-deficient osteoblasts still express Runx2 (Nakashima et al. 2002) and the transcription of 
Osx is positively regulated by Runx2 (Celil, Hollinger, and Campbell 2005). Interestingly, 
although expression of Osx in vivo requires Runx2, BMP-2 is still able to stimulate Osx 
expression in Runx2-deficient cells (Lee et al. 2003). Moreover, recent data have indicated that 
BMP-2 activates expression of Osx through Runx2-dependent as well as -independent 
mechanisms involving Dlx5 and Msx2 (Ulsamer et al. 2008; Matsubara et al. 2008).  
Other than Runx2 and Osx, various transcription factors have been identified as important 
regulators of osteoblast differentiation. They include ATF4, activator protein 1 (AP1), 
homeobox proteins (Msx1, Msx2, Dlx5, Dlx6), and CCAAT/enhancer-binding proteins 
(C/EBPs) (Marie 2008). ATF4, also known as cAMP-response element-binding protein 2 
(CREB2), is a basic leucine-zipper transcriptional factor that belongs to ATF/CREB protein 
family (Karpinski et al. 1992). Similar to Runx2 and Osx, an essential role of ATF4 in bone 
development in vivo was revealed by a study using ATF4-deficient mice, which showed a 
marked reduction in bone mineralization and trabecular development throughout life (Yang 
et al. 2004). The promoting effects of ATF4 on bone development is not through the 
modulation of Runx2 or Osx expression level, as ATF4-deficient mice showed normal 
expression levels of these two transcriptional factors (Yang et al. 2004).  
2.2 Osteoblasts as immune-regulatory cells 
Bone tissue often becomes the site of inflammation caused by infection, auto-immune 
responses, and mechanical stresses. Recent lines of evidence have indicated that osteoblasts 
are important immune-regulatory cells controlling inflammatory responses in bone tissue. 
We and others have previously shown that osteoblasts express several members of Toll-like 
receptors (TLRs) which sense microbe infection by binding pathogen-associated molecular 
patterns (PAMPs) such as lipopolysaccharide (LPS) (Kikuchi et al. 2001; Kikuchi et al. 2003; 
Amcheslavsky et al. 2005). Stimulation of osteoblasts through TLRs induce the production of 
RANKL and TNF-, both of which activate osteoclast-mediated bone resorption (Kikuchi et 
al. 2001; Kikuchi et al. 2003; Hayashi et al. 2003).  
It has been reported that in inflammatory bone tissues, osteoblasts also express chemokines 
including monocyte chemoattractant protein (MCP)-1, macrophage-inflammatory protein 
(MIP)-1, RANTES (Lisignoli et al. 2002) and interleukin (IL)-8 (Bendre et al. 2003). These 
chemokines attract monocytes, macrophages and T cells through CC chemokine receptor 1 
(CCR1), CCR2, CCR3, CCR5, and CXC chemokine receptor1 (CXCR1) (Yoshie, Imai, and 
Nomiyama 2001). Interestingly, IL-8 has recently been shown to increase the motility of 
osteoclasts and directly induce their differentiation through both RANKL-dependent and 
independent pathways (Bendre et al. 2003).  
2.3 Effects of mechanical stresses on osteoblast functions 
Mechanical loading to the skeleton is important for the development and maintenance of 
strong and healthy bones. Significant bone loss is often encountered due to long-term 
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immobilization, which has become an increasing social problem. Being located in the 
skeletons, osteoblasts are constantly exposed to various forms of mechanical stresses. Many 
previous studies have indicated that mechanical stresses on osteoblasts affect their cell 
proliferation, survival, and differentiation processes, which may explain why moderate 
exercises contribute to healthy bone development. However, mechanical stresses often 
induce tissue inflammation in bones, especially when they are excessive. We and others 
have recently revealed that osteoblasts respond to mechanical stresses by expressing various 
inflammatory cytokines and chemokines (Bandow et al. 2007; Maeda et al. 2007). 
3. Kinases involved in osteoblast differentiation  
As briefly discussed in 2.1, several transcription factors including Runx2, Osx, and ATF4 
have been demonstrated to be crucial for bone development. However, the molecular details 
of intracellular kinases controlling stage-specific osteoblast differentiation remain enigmatic. 
The biggest reason, I presume, is that the expression of most kinases remains relatively 
constant during osteoblast differentiation, unlike some transcription factors whose 
expression is clearly induced in differentiation stage-specific manners. Here I list some of 
the reported kinases whose activities are functionally associated with osteoblast 
differentiation. 
3.1 MAPKs  
It is well recognized that the MAPK superfamily, including p44/p42 ERKs, p38 kinases, and 
p54/p46 JNKs, integrates signals from a diverse range of extracellular stimuli, and plays 
important roles in cellular functions such as proliferation, differentiation, and cell death in a 
variety of cell types (Widmann et al. 1999). Activation of MAPKs requires dual 
phosphorylation of Tyr and Thr residues in the activation loop of the molecules, which is 
catalized by a family of dual specificity kinases termed MAPK kinases (MKKs). Conversely, 
their dephosphorylation is catalyzed by dual specificity phosphatases termed MAPK 
phosphatases (MKPs). Among MKP family members, some show highly selective substrate 
specificity, whereas others efficiently inactivate all three classes of MAPKs. We previously 
cloned an MKP termed MKP-M (also referred to as DUSP16 or MKP-7) (Matsuguchi et al. 
2001; Masuda et al. 2001; Tanoue et al. 2001), which preferentially inactivates JNKs 
(Matsuguchi et al. 2001; Masuda et al. 2001).  
The role of ERKs in osteoblast differentiation has been studied with inconsistent results. In 
recent reports, matrix mineralization of MC3T3-E1 cells (a mouse osteoblastic cell line) and 
preosteocytic MLO-A5 cells was increased by an inhibitor of MEK1/2 that are upstream 
activators of ERKs (Kono et al. 2007). In contrast, selective expression of a constitutively active 
form of ERK1 by a transgenic approach accelerated in vitro differentiation of mouse calvaria 
cells, as well as in vivo bone development in mice (Ge et al. 2007). We additionally observed 
that matrix mineralization by MC3T3-E1 cells was enhanced by an MEK1/2 inhibitor, whereas 
the same inhibitor clearly inhibited matrix mineralization of primary osteoblasts from mouse 
calvaria, indicating the regulatory role of ERKs in osteogenic differentiation may vary 
depending on the cell types or differentiation stages of osteoblasts (Matsuguchi et al. 2009).  
Being similar to ERKs, the role of p38 kinase in osteoblast differentiation is also disputable. 
BMP2 is known to activate p38 kinase in osteoblasts. Kinase activity of p38 kinase was 
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reported to be stimulatory (Gallea et al. 2001) or inhibitory (Vinals et al. 2002) in BMP-2-
induced osteoblast differentiation. Noticeably, it has recently been reported that p38 kinase 
phosphorylates Osx at Ser-73/77 (Ortuno et al. 2010). Phosphorylatied Osx showed 
increased ability to recruit coactivators including p300 and SWI/SNF leading to the 
formation of transcriptionally active complexes, indicating the possibility that p38 exerts 
promotion of osteoblast differentiation by phosphorylating Osx.   
JNK was originally identified by its ability to specifically phosphorylate the transcription 
factor c-Jun on its N-terminal transactivation domain (Hibi et al. 1993). JNK consists of three 
isoforms (JNK1, 2 and 3) deriving from distinct genes. Among them, JNK1 and JNK2 are 
ubiquitously expressed while JNK3 is mainly expressed in brain, testis, and heart (Kyriakis 
and Avruch 2001). Alternative splicing at the C-terminus yields 46 kDa and 54 kDa 
polypeptides for each JNK isoform. The 46kDa form is predominant for JNK1, whereas the 
54kDa form is predominant for JNK2 and JNK3. Although JNK1 and JNK2 possess 
structural similarities and many overlapping biological functions, recent evidences have 
revealed some functional differences between the two kinases (Sabapathy et al. 2004; Liu, 
Minemoto, and Lin 2004). We have recently found that the terminal osteoblastic 
differentiation was significantly inhibited by the treatment with a specific JNK inhibitor as 
well as the over-expression of MKP-M, a JNK-specific MKP (Matsuguchi et al. 2009). 
Conversely, enhanced matrix mineralization was observed by inducible overexpression of 
p54JNK2 in an isoform-specific manner. More specifically, JNK inhibition significantly 
suppressed the late stage molecular events of osteoblastic differentiation, such as gene 
expression of Ocn and Bsp. In contrast, earlier differentiation events including alkaline 
phosphatase (ALP) activation and Opn expression were not inhibited by JNK inactivation. 
As for transcriptional factors, induction of ATF4 expression during osteoblastic 
differentiation was significantly inhibited, whereas the expression levels of Runx2 and Osx, 
were not significantly affected by JNK inactivation. Thus JNK activity is essential for the 
late-stage differentiation of osteoblasts. 
3.2 Phosphoinositide3-Kinase (PI3K)-akt signaling pathway  
Various cytokines and growth factors activate PI3K to produce phosphatidylinositol 3,4,5-
phosphate (PIP3), which then recruits and activates Akt. Akt has been shown to be activated 
by BMPs in osteoblasts (Ghosh-Choudhury et al. 2002). Deletion of Akt1, the major form of 
Akt in osteoblasts, in mice results in osteopenia caused by the inhibition of differentiation 
and the increase of apoptosis of osteoblasts (Kawamura et al. 2007). Conversely, osteoblast-
specific deletion of Pten, an inhibitory phosphatase of PI3K, by Ocn-Cre system in mice 
induced progressive increases in bone volume and density throughout life (Liu et al. 2007). 
The isolated Pten-defective osteoblasts showed accelerated differentiation capacity and 
decreased susceptibility to apoptosis. These results indicated that the PI3K-Akt signal is 
promotive of osteoblasts differentiation and inhibitory to osteoblast apoptosis. Consistently, 
it has been shown that Akt is essential for Runx2 indcution in osteoblasts by IGF-I, a known 
osteogenic growth factor. 
3.3 Glycogen synthase kinase 3 (GSK3) in Wnt signals 
Wnt family proteins play important roles in both embryogenesis and postnatal 
development. Wnts bind their cell surface receptor, Frizzled (Frz) in combination with the 
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co-receptors, low density lipoprotein receptor-related protein (LRP) 5/6. The activated 
receptors induce the inactivation of a serine/threonine kinase, GSK3. In the steady-state 
cells, GSK3 form a complex with -Catenin and phosphorylates it leading to its ubiquitin-
mediated degradation (Cadigan and Liu 2006). When Wnt is signal is on, GSK3-mediated -
Catenin degradation is off, leading to the accumulation of -Catenin in the nucleus. Nuclear 
-Catenin forms a complex with a transcription factor, TCF/LEF, activating the 
transcription of a series of Wnt-target genes including Runx2 in osteoblasts. This GSK3-
mediated cannonical pathway is responsible for the osteogenic activity of Wnts, as inhibitors 
of GSK3 stimulate osteoblastgenesis in vitro and in vivo (Kulkarni et al. 2006).  
Involvemennt of GSK3 in the synergestic effects of Wnt and BMP-4 on 
osteoblastic differentiation has recently been reported (Fukuda et al. 2010). Wnt3a, a 
canonical Wnt, synergistically stimulated ColI expression and ALP activity in the presence 
of BMP-4. Interestingly, overexpression of -Catenin did not affect BMP-4-induced ALP 
activity, whereas inhibition or stimulation of GSK3 activity resulted in either stimulation or 
suppression of ALP activity, respectively, in the presence of BMP-4. This finding indicated 
that GSK3 mediates synergy of BMP-4 and Wnt3a to promote osteoblastic differentiation 
through a -Catenin-independent mechanism. 
3.4 AMP-Activated Protein Kinase (AMPK) 
AMP-activated protein kinase (AMPK) is a serine-threonine kinase widely known as a 
regulator of cell metabolism (Hardie 2007). AMPK is a hetero-trimeric protein consisting of 
the catalytic  subunit and the regulatory  and  subunits in a 1:1:1 stoichiometric ratio. As 
several isoforms have been identified for each subunit (1-2; 1-2; 1-3), 12 combinations are 
possible, which show relative tissue specificity (Cheung et al. 2000). AMPK is activated by 
cellular stresses with increased AMP:ATP ratio as in calorie restriction. Subsequently, ATP-
generating pathways are activated, while ATP-consuming mechanisms are inhibited, 
thereby restoring the cellular AMP:ATP ratio. AMPK is thus considered as an essential 
regulator of energy homeostasis, and termed as a metabolic “energy sensor” of the 
biological system. The activation of AMPK is through phosphorylation of the catalytic  
subunit by an upstream kinase (Hawley et al. 1996).The most characterized upstream 
AMPK kinase (AMPKK) is LKB1, which is a reported target of metformin, a type 2 diabetes 
drug (Shaw et al. 2005). 
Intriguingly, recent studies have revealed non-metabolic functions of AMPK, such as the 
regulation of cell polarity and mitosis (Lee et al. 2007), and mammal longevity (McCarty 
2004). Several lines of evidence have also indicated the involvement of AMPK in the 
regulation of cellular differentiation. Activation of AMPK was suggested to be inhibitory to 
the differentiation of adipocytes (Dagon, Avraham, and Berry 2006; Giri et al. 2006; 
Habinowski and Witters 2001; Hwang et al. 2005; Tong et al. 2008), and myoblasts (Fulco et 
al. 2008), and promotive to the differentiation of endothelial progenitor cells (Li et al. 2008). 
We have recently explored the role of AMPK in osteoblast differentiation using in vitro 
differentiation models (Kasai et al. 2009). We found that the phosphorylation of AMPK 
was progressively decreased during osteoblastic differentiation. Conversely, osteoblast 
differentiation was significantly inhibited by glucose restriction and treatment with 
metformin, both of which are known activators of AMPK, as well as the forced expression of 
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a constitutively active form of AMPK. Metformin stimulation of osteoblasts significantly 
inhibited gene expression of Runx2 along with osteogenic markers including Ocn, Bsp, and 
Opn. Our result is consistent with a recent report showing the inhibitory effects of AMPK 
activators on Wnt/-Catenin signaling in human osteoblastic cells (Takatani et al. 2011). In 
contrast to our result, treatment by metformin was previously reported to promote 
osteoblast differentiation (Cortizo et al. 2006; Kanazawa et al. 2008). We presume that the 
inconsistent results were due to the different dose of metformin used in experiment. The 
previous reports used metformin at much lower concentrations than we did, which might 
not be sufficient to induce sustained AMPK phosphorylation (Kasai et al. 2009). Thus the 
effects of AMPK activity on osteoblast differentiation may vary in a dose-dependent fashion. 
4. Kinases involved in mechanotransduction of osteoblasts 
It has been well established that the load-induced mechanical stresses significantly affect 
cellular functions of osteoblasts. Mechanical stresses have been reported to be associated 
with increased proliferation, accelerated differentiation, and inhibition of apoptosis of 
osteoblasts (Aguirre et al. 2006; Robling and Turner 2009; Turner et al. 2009). Recent lines of 
evidence have also revealed that mechanical stresses induce the expression of RANKL, 
inflammatory cytokines, and chemokines by osteoblasts (Bandow et al. 2007; Maeda et al. 
2007). However, the reception and intracellular signals transducing these stresses (termed as 
mechanotransduction) of osteoblasts are not well understood. What makes things more 
complicated is that there are various types of mechanical stresses. They include compression 
(static or cyclic), tension (static and cyclic), shear stress (including fluid shear stress), 
ultrasound, and others. It should be considered that the mechanotrasduction mechanisms 
for different types of stresses may significantly vary. Moreover, intensity and frequency for 
each type of mechanical stress may also affect the induced molecular events in cells. Here, I 
will review some of the kinases previously identified as mechanotransducers of osteoblasts. 
4.1 MAPKs 
4.1.1 ERKs 
It has been reported that in osteoblasts ERKs are activated by mechanical stimuli including 
fluid shear stress (You et al. 2001; Kapur, Baylink, and Lau 2003; Weyts et al. 2002), 
compression by centrifugation (Hatton et al. 2003), cyclic stretch (Jessop et al. 2002), 
magnaetic drag force (Pommerenke et al. 2002), and ultrasound (Bandow et al. 2007) (Fig. 2). 
At least in our hands, it is the MAPK most evidently activated by cyclic stretch (unpublished 
result) and ultrasound (Bandow et al. 2007). Osteoblast proliferation induced by cyclic 
stretch requires the activation of ERKs as the treatment with a specific inhibitor of the ERK 
activating pathway abrogated the proliferation-promoting activity of cyclic stretch 
(Boutahar et al. 2004). ERK activation has also been reported to be essential for the fluid 
shear stress to stimulate osteoblast differentiation (Kido et al. 2009). Furthermore, a previous 
report has indicated that the stretch-induced anti-apoptotic effect on osteoblasts requires the 
activation of ERKs but not PI3K or p38 kinase (Plotkin et al. 2005). This anti-apoptotic effect 
involves the nuclear translocation of ERKs and new gene transcription (Plotkin et al. 2005). 
The upstream mechanisms mediating mechanical activation of ERKs have been proposed for 
some experimental systems (Fig. 2). It has previously been shown that integrins are essential  
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Fig. 2. Working model: Mechanical stress-sensing mechanisms of osteoblasts. ERKs are 
activated by various types of mechanical stress and initiate multiple cellular functions. 
for the activation of ERKs in osteoblasts by cyclic stretch (Schmidt et al. 1998; Zhang et al. 
2003). We have recently reported that the treatment of osteoblasts by low-intensity pulsed 
ultrasound (LIPUS) induced ERK activation and the expression of chemokine and RANKL 
(Bandow et al. 2007). These LIPUS-induced cellular events were abrogated by candesaltan, a 
specific inhibitor of angiotensin II type 1 receptor (AT1). AT1 is a known mechanoreceptor 
in cardiomyocytes (Zou et al. 2004). Osteoblasts express AT1 mRNA and protein and the 
level of expression increased significantly during osteoblast differentiation (Bandow et al. 
2007). These findings indicate that AT1 functions as a mechanoreceptor of in osteoblasts as 
well as in cardiomyocytes. Another example is P2X7, a two-transmembrane ionotropic 
receptor. P2X7 has been reported as a mechanotransducer of osteoblasts, which is essential 
for the ERK activation by fluid shear stress (Liu et al. 2008), indicating that ERK activation 
by fluid shear stress is dependent on intracellular Ca2+. 
In addition, multiple autocrine and paracrine factors have been implicated to transduce ERK 
activation by mechanical stresses. For example, ERK activation in osteoblasts by fluid shear 
stress has been reported to be dependent on nitric oxide (NO) synthesis (Rangaswami et al. 
2009; Kapur, Baylink, and Lau 2003). According to another report, however, synthesis of NO 
and prostacyclin is essential for ERK activation in osteoblasts induced by mechanical stretch, 
but not by fluid shear stress (Jessop et al. 2002). 
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4.1.2 JNKs and p38 Kinase 
Transient activation of JNKs in osteoblasts has been reported to be induced by cyclic stretch 
(Danciu et al. 2003), compression (Maeda et al. 2007), and fluid shear stress (Lee et al. 2008; 
Wang et al. 2011). It has been reported that JNK activity is important for compression-
induced IL-8 expression (Maeda et al. 2007). On the other hand, transient activation of p38 
kinase in osteoblasts has been reported to be induced by cyclic stretch (Kusumi et al. 2005), 
compression (Maeda et al. 2007), fluid shear stress (Lee et al. 2008; Yeh et al. 2010), and 
magnetic force (Yuge et al. 2003). Recent reports indicated that p38 activation is essential for 
Opg expression induced by cyclic stretch (Kusumi et al. 2005), and compression-induce IL-8 
expression (Maeda et al. 2007). Intriguingly, acceleration of osteoblast differentiation 
induced by magnetic force is mainly attributed to p38 kinase activation, while the activity of 
ERKs or JNKs is dispensable (Yuge et al. 2003). Thus p38 kinase may be specifically 
involved in the mechanotransduction of magnetic force in osteoblasts. 
Activation of JNKs and p38 kinase by cyclic stretch in osteoblasts, however, is not as 
universally observed as that of ERKs and sometimes controversial. For example, a previous 
report showed that the application of cyclic stretch to human osteoblasts induced 
phosphorylation of ERKs, but not JNKs or p38 kinase (Zhu et al. 2009). Additionally, we 
found that cyclic stretch did not induce JNK or p38 kinase phosphorylation in mouse 
osteoblast cell lines or mouse primary osteoblasts, whereas it induced significant ERK 
phosphorylation (unpublished results). Thus, activation of JNKs and p38 kinase by cyclic 
stretch may be cell line-specific or dependent on stretch conditions.  
4.2 Integrin-associated kinases 
Cells are surrounded by ECM, which profoundly affects cellular functions. Most effects 
from ECM are mediated through integrins, cell surface receptors responsible for cell 
attachment to and reception of signals from ECM. As integrins lack intracellular enzymatic 
domains, signals from ECM are transduced by various intracellular signaling molecules, the 
most crucial of which is focal adhesion kinase (FAK) (Fig. 2). Integrin engagement induces 
activation and the subsequent autophosphorylation of FAK, which then interacts with 
another tyrosine kinase, Src. These molecular events eventually lead to the activation of 
ERKs (Bellido 2010). Integrins have been shown as important mechanotransducers in 
various cell types including osteoblasts. 
4.2.1 FAK 
As FAK-null mice are embryonic lethal (Furuta et al. 1995), mice with conditional knock-out 
of FAK in osteoblasts have been generated (Kim et al. 2007). Although these mice were 
normal in basal osteoblast differentiation, they were defective in bone healing due to 
decreased matrix deposition, which may be caused by defective mechanotransduction of 
osteoblasts. The role of FAK in osteoblasts has also been explored in vitro. Fluid shear stress-
induced osteoblast differentiation as well as activation of ERK and JNK was blocked by the 
expression of a dominant negative FAK mutant, indicating the essential role of FAK in 
mechanotransduction of fluid shear stress (Wang et al. 2011). It has also been reported that 
FAK-/- osteoblasts are unresponsive to fluid shear stress in ERK activation and Opn 
expression (Young et al. 2011).  
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4.2.2 Src 
A well-known tyrosine kinase, Src, is involved in integrin signals downstream of FAK. The 
role of Src in mechanotransduction of osteoblasts has recently been examined. Fluid shear 
stress induced increased phosphorylation at Tyr-416 of Src in osteoblasts (Morgan et al. 
2011). Inhibition of Src, however, had no effects on fluid shear stress-induced Opn 
expression or ERK activation. These findings indicate that Src is activated by fluid shear 
stress but not necessary for the proper mechanotransduction of osteoblasts. Another recent 
report indicated that protein kinase G (PKG), which is activated by NO-mediated 
production of cGMP, induced the activation of Src in mechanically stimulated osteoblasts 
(Rangaswami et al. 2010). Activation of Src by PKG is necessary for the interaction of Src 
with 3 integrin, indicating that Src functions as a converging point of integrin and NO-PKG 
signals in osteoblasts. 
4.3 PI3K-Akt activating pathway 
Sustained activation of PI3K in osteoblasts by fluid shear stress has been reported (Lee et al. 
2010) (Fig. 2). The resultant activation of Akt, mTOR, and p70S6 kinase leads to cell 
proliferation. The fluid shear stress-induced activation of PI3K appears to be induced by a 
complex formation of PI3K p85 subunit with V3/1 integrins, Shc, and FAK. It has also 
been reported that PI3K-Akt pathway activated by fluid shear stress in osteoblasts and 
osteocytes, induces increased nuclear translocation of -Catenin (Kitase et al. 2010; Xia et al. 
2010), as Akt phosphorylates and inactivates GSK3 (Wang, Brown, and Martin 2011). The 
increased -Catenin signal by fluid shear stress is essential for anti-apoptotic effects against 
glucocorticoid, indicating a possible mechanism how mechanical loading sustains healthy 
bone structure. 
4.4 LIM Kinase 2 (LIMK2) 
When osteoblasts are loaded with mechanical stress, the structure of actin cytoskeleton is 
reorganized, which results in changes of cell stiffness (Jaasma et al. 2007). LIM kinase 
(LIMK) is a unique protein kinase that has two LIM domain repeats at the N-terminus, 
followed by a PDZ domain and a catalytic kinase domain. LIMK protein family includes 
two members, LIMK1 and LIMK2. LIMK1 is highly expressed in neural tissues (Takahashi, 
Funakoshi, and Nakamura 2003), whereas LIMK2 is widely expressed in various tissues 
(Acevedo et al. 2006). LIMK2 phosphorylates and inactivates cofilin, an actin-
depolymerizing factor, thereby inducing actin cytoskeleton reorganization (Takahashi, 
Funakoshi, and Nakamura 2003). A recent report explored the functional role of LIMK2 in 
osteoblasts treated with fluid shear stress (Fu et al. 2008). Gene silencing of LIMK2 in 
osteoblasts by siRNA clearly decreased reorganization of actin cytoskeleton induced by 
fluid shear stress. This finding indicates an important role of LIMK2 in osteoblasts with 
mechanical loading. 
5. Conclusion  
Bone is a dynamic tissue where constant remodelling is going on. Osteoblasts are unique 
cells with multiple aspects. They (1) differentiate into osteocytes, the main cell type in bone 
tissue, (2) produce proteins for the formation of bone matrix, (3) recruit osteoclasts and 
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control their function, thus playing a regulatory role in bone remodelling, (4) sensing the 
degree and nature of mechanical loading, which are necessary for the proper maintenance of 
bone structure suitable for the environment, (5) sense infection and recruit inflammatory 
cells for host defence. As I have discussed in this review, many of the multiple functions of 
osteoblasts are controlled by a list of kinases. It should be noted that the same kinases, such 
as MAPKs and PI3Ks, are involved in many functions of osteoblasts. Thus, in osteoblasts, a 
lot of crosstalk exists among signal transduction pathways through kinases. If this 
complicated network is broken due to kinase malfunction, it certainly leads to bone 
metabolic disorders. In concluding, this review may provide insights into a new list of 
therapeutic target molecules for diseases that have become threatening social problems, 
such as osteoporosis. 
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